Multi-center phase II/III randomized controlled clinical trial using TNFerade combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC)

被引：0
|
作者：
Posner, M.
Chang, K. J.
Rosemurgy, A.
Stephenson, J.
Khan, M.
Reid, T.
Fisher, W. E.
Waxman, I.
Von Hoff, D.
Hecht, R., Jr.
机构：
[1] Univ Chicago Hosp, Chicago, IL 60637 USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
[3] Univ S Florida, Tampa, FL USA
[4] Canc Ctr Carolinas, Greenville, SC USA
[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
[7] Michael E DeBakey Dept Surg, Houston, TX USA
[8] Univ Chicago, Chicago, IL 60637 USA
[9] Translat Genom Res Inst, Phoenix, AZ USA
[10] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4518
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC)
    Evans, T. R. Jeffry
    Eatock, Martin McKinlay
    Lewsley, Liz-Anne
    Kelly, Caroline
    McCartney, Elaine
    Duffton, Aileen
    Houston, Peter
    Harrison, Claire
    Purcell, Colin
    Ashton, Miranda
    Morton, Alanna
    Graham, Jill
    Chalmers, Anthony J.
    Thomson, Fiona
    Pou, Chantevy
    Bilsland, Alan
    Cooke, Susie
    McIntosh, David
    Grose, Derek B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [22] A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial
    Anders Jakobsen
    John Pløen Mortensen
    Claus Bisgaard
    Jan Lindebjerg
    Søren Rafael Rafaelsen
    Vagn Ove Bendtsen
    International Journal of Colorectal Disease, 2008, 23 : 251 - 255
  • [23] Induction Chemotherapy in Locally Advanced Pancreatic Cancer (LAPC) - Final Results of a Multicenter Randomized Phase 2 AIO Trial (NEOLAP)
    Hartlapp, Ingo
    Alguel, Hana
    Goekkurt, Eray
    Siegler, Gabriele
    Martens, Uwe
    Waldschmidt, Dirk
    Pelzer, Uwe
    Hennes, Elke
    Fuchs, Martin
    Siveke, Jens
    Kullmann, Frank
    Boeck, Stefan
    Ettrich, Thomas J.
    Ferenczy, Peter
    Keller, Ralph
    Germer, Christoph-Thomas
    Stein, Hubert
    Klein, Ingo
    Heinemann, Volker
    Kunzmann, Volker
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 63 - 63
  • [24] A phase II study of induction chemotherapy with gemcitabine plus S-1 (GS) followed by chemoradiation for locally advanced pancreatic cancer (LAPC)
    Nakachi, K.
    Furuse, J.
    Kinoshita, T.
    Kawashima, M.
    Ishii, H.
    Suzuki, E.
    Shimizu, S.
    Yoshino, M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 270 - 270
  • [25] Impact of gemcitabine (Gem)-or capecitabine (Cape)-based chemoradiation (CRT) on health-relatedquality of life (HRQL) in patients with locally advanced pancreatic cancer (LAPC): Outcomes from the randomized phase II SCALOP trial.
    Mukherjee, Somnath
    Hurt, Chris
    Dutton, Peter
    Bridgewater, John A.
    Crosby, Thomas
    Mcdonald, Alec
    Falk, Stephen
    Abrams, Ross A.
    Maughan, Tim
    Griffiths, Gareth
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Multi-Center Clinical Trial Using Endoscopy (END) and Endoscopic Ultrasound (EUS) Guided Fine Needle Injection (FNI) of Anti-Tumor Agent (TNFerade™) in Patients with Locally Advanced Esophageal Cancer
    Chang, Kenneth J.
    Senzer, Neil
    Swisher, Stephen
    Reid, Tony
    Mauer, Ann
    Posner, Mitchell
    Pinto, Harlan
    Forastiere, Arlene
    Soetikno, Roy
    Macko, Jennifer
    Nemunaitis, John
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB84 - AB84
  • [27] A randomized, phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE Trial
    Ledermann, Jonathan
    McCormack, Mary
    Gallardo Rincon, Dolores
    Eminowicz, Gemma
    Diez, Patricia
    Farrelly, Laura
    Kent, Christopher
    Hudson, Emma
    Panades, Miguel
    Mathew, Tony
    Anand, Anjana
    Persic, Mojca
    Forrest, Jennifer
    Bhana, Rajanee
    Reed, Nick
    Drake, Anne
    Stobart, Hilary
    Mukhopadhyay, Asima
    Hacker, Anne-Marie
    Hackshaw, Allan
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S21 - S21
  • [28] Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial
    da Costa, Samantha Cabral S.
    Bonadio, Renata Colombo
    Gabrielli, Flavia Carolina G.
    Aranha, Andrea S.
    Dias Genta, Maria Luiza N.
    Miranda, Vanessa C.
    de Freitas, Daniela
    Abdo Filho, Elias
    Ferreira, Patricia A. O.
    Machado, Karime K.
    Scaranti, Mariana
    Carvalho, Heloisa de A.
    Estevez-Diz, Maria Del Pilar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (33) : 3124 - +
  • [29] Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
    Ishikawa, Takeshi
    Kokura, Satoshi
    Sakamoto, Naoyuki
    Ando, Takashi
    Imamoto, Eiko
    Hattori, Takeshi
    Oyamada, Hirokazu
    Yoshinami, Naomi
    Sakamoto, Masafumi
    Kitagawa, Kazutomo
    Okumura, Yoko
    Yoshida, Naohisa
    Kamada, Kazuhiro
    Katada, Kazuhiro
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Yasuda, Hiroaki
    Sakagami, Junichi
    Konishi, Hideyuki
    Yagi, Nobuaki
    Naito, Yuji
    Yoshikawa, Toshikazu
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2012, 28 (07) : 597 - 604
  • [30] KRAS mutation analysis in patients (pts) with locally advanced pancreatic cancer (LAPC) treated with gefitinib and chemoradiation therapy (CT-RT) in a phase I trial.
    Chen, H.
    Raben, D.
    Schefter, T.
    Kane, M.
    McCarter, M.
    Olsen, C.
    McCoy, K.
    Eckhardt, S. G.
    Gumerlock, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 204S - 204S
12345